oxidopamine has been researched along with Syndrome in 5 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The tachycardia was abolished by treatment with the beta-antagonist propranolol, demonstrating that it was mediated by catecholamines acting on cardiac beta-receptors." | 1.31 | Animal model of neuropathic tachycardia syndrome. ( Appalsamy, M; Carson, RP; Davis, TL; Diedrich, A; Robertson, D, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nadaud, D | 1 |
| Simon, H | 1 |
| Herman, JP | 1 |
| Le Moal, M | 1 |
| Atadzhanov, M | 1 |
| Casas, M | 1 |
| Prat, G | 1 |
| Robledo, P | 1 |
| Barbanoj, M | 1 |
| Kulisevsky, J | 1 |
| Jané, F | 1 |
| Carson, RP | 1 |
| Appalsamy, M | 1 |
| Diedrich, A | 1 |
| Davis, TL | 1 |
| Robertson, D | 1 |
| Naryshkin, AG | 1 |
| Poltavchenko, GM | 1 |
| Chuvaev, IV | 1 |
| Cherkasova, AV | 1 |
1 review available for oxidopamine and Syndrome
| Article | Year |
|---|---|
[Modeling parkinsonism (review)].
Topics: Aluminum; Animals; Carbachol; Cats; Caudate Nucleus; Chlorides; Chlorpromazine; Disease Models, Anim | 1982 |
4 other studies available for oxidopamine and Syndrome
| Article | Year |
|---|---|
Contributions of the mesencephalic dopaminergic system and the trigeminal sensory pathway to the ventral tegmental aphagia syndrome in rats.
Topics: Animals; Corpus Striatum; Dopamine; Drinking Behavior; Feeding Behavior; Hydroxydopamines; Male; Mes | 1984 |
Methylxanthines reverse the adipsic and aphagic syndrome induced by bilateral 6-hydroxydopamine lesions of the nigrostriatal pathway in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Caffeine; Corpus | 2000 |
Animal model of neuropathic tachycardia syndrome.
Topics: Adrenergic Agents; Animals; Autonomic Nervous System Diseases; Blood Pressure; Disease Models, Anima | 2001 |
[The postamputation syndrome in rats and its neurochemical characteristics].
Topics: 5,7-Dihydroxytryptamine; Amputation, Surgical; Amputation, Traumatic; Animals; Cyclic AMP; Cyclic GM | 1992 |